カテゴリ： Market Monitor Global, 世界, 医療/バイオ

麻疹・風疹（MR）ワクチンのグローバル市場展望 2023年-2029年：MRワクチン、MRBEVワクチン

■ 英語タイトル：Measles and Rubella (MR) Vaccine Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5739）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5739
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆医療
■ ページ数：79
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[麻疹・風疹（MR）ワクチンのグローバル市場展望 2023年-2029年：MRワクチン、MRBEVワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の麻疹・風疹（MR）ワクチン市場規模と予測を収録しています。・世界の麻疹・風疹（MR）ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の麻疹・風疹（MR）ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の麻疹・風疹（MR）ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「MRワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

麻疹・風疹（MR）ワクチンのグローバル主要企業は、PT Bio Farma、 Bio-Manguinhos、 BE Vaccines、 Crucell Switzerland AGなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、麻疹・風疹（MR）ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の麻疹・風疹（MR）ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の麻疹・風疹（MR）ワクチン市場：タイプ別市場シェア、2022年
・MRワクチン、MRBEVワクチン

世界の麻疹・風疹（MR）ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の麻疹・風疹（MR）ワクチン市場：用途別市場シェア、2022年
・プライベート流通チャネル、パブリック流通チャネル

世界の麻疹・風疹（MR）ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の麻疹・風疹（MR）ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における麻疹・風疹（MR）ワクチンのグローバル売上、2018年-2023年
・主要企業における麻疹・風疹（MR）ワクチンのグローバル売上シェア、2022年
・主要企業における麻疹・風疹（MR）ワクチンのグローバル販売量、2018年-2023年
・主要企業における麻疹・風疹（MR）ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
PT Bio Farma、 Bio-Manguinhos、 BE Vaccines、 Crucell Switzerland AG

*************************************************************

・調査・分析レポートの概要
麻疹・風疹（MR）ワクチン市場の定義
市場セグメント
世界の麻疹・風疹（MR）ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の麻疹・風疹（MR）ワクチン市場規模
世界の麻疹・風疹（MR）ワクチン市場規模：2022年 VS 2029年
世界の麻疹・風疹（MR）ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの麻疹・風疹（MR）ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の麻疹・風疹（MR）ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：MRワクチン、MRBEVワクチン
麻疹・風疹（MR）ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：プライベート流通チャネル、パブリック流通チャネル
麻疹・風疹（MR）ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別麻疹・風疹（MR）ワクチン市場規模 2022年と2029年
地域別麻疹・風疹（MR）ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
PT Bio Farma、 Bio-Manguinhos、 BE Vaccines、 Crucell Switzerland AG
...

This report aims to provide a comprehensive presentation of the global market for Measles and Rubella (MR) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles and Rubella (MR) Vaccine. This report contains market size and forecasts of Measles and Rubella (MR) Vaccine in global, including the following market information:
Global Measles and Rubella (MR) Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Measles and Rubella (MR) Vaccine Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Measles and Rubella (MR) Vaccine companies in 2022 (%)
The global Measles and Rubella (MR) Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
MR Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Measles and Rubella (MR) Vaccine include PT Bio Farma, Bio-Manguinhos, BE Vaccines and Crucell Switzerland AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Measles and Rubella (MR) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles and Rubella (MR) Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, by Type, 2022 (%)
MR Vaccine
MRBEV Vaccine
Global Measles and Rubella (MR) Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, by Application, 2022 (%)
Private Distribution Channel
Public Distribution Channel
Global Measles and Rubella (MR) Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Measles and Rubella (MR) Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Measles and Rubella (MR) Vaccine revenues share in global market, 2022 (%)
Key companies Measles and Rubella (MR) Vaccine sales in global market, 2018-2023 (Estimated), (Units)
Key companies Measles and Rubella (MR) Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
PT Bio Farma
Bio-Manguinhos
BE Vaccines
Crucell Switzerland AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Measles and Rubella (MR) Vaccine, market overview.
Chapter 2: Global Measles and Rubella (MR) Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Measles and Rubella (MR) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Measles and Rubella (MR) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Measles and Rubella (MR) Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Measles and Rubella (MR) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Measles and Rubella (MR) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Measles and Rubella (MR) Vaccine Overall Market Size
2.1 Global Measles and Rubella (MR) Vaccine Market Size: 2022 VS 2029
2.2 Global Measles and Rubella (MR) Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Measles and Rubella (MR) Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Measles and Rubella (MR) Vaccine Players in Global Market
3.2 Top Global Measles and Rubella (MR) Vaccine Companies Ranked by Revenue
3.3 Global Measles and Rubella (MR) Vaccine Revenue by Companies
3.4 Global Measles and Rubella (MR) Vaccine Sales by Companies
3.5 Global Measles and Rubella (MR) Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Measles and Rubella (MR) Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Measles and Rubella (MR) Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Measles and Rubella (MR) Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Measles and Rubella (MR) Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Measles and Rubella (MR) Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Measles and Rubella (MR) Vaccine Market Size Markets, 2022 & 2029
4.1.2 MR Vaccine
4.1.3 MRBEV Vaccine
4.2 By Type – Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
4.2.1 By Type – Global Measles and Rubella (MR) Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Measles and Rubella (MR) Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Measles and Rubella (MR) Vaccine Sales & Forecasts
4.3.1 By Type – Global Measles and Rubella (MR) Vaccine Sales, 2018-2023
4.3.2 By Type – Global Measles and Rubella (MR) Vaccine Sales, 2024-2029
4.3.3 By Type – Global Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Measles and Rubella (MR) Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Measles and Rubella (MR) Vaccine Market Size, 2022 & 2029
5.1.2 Private Distribution Channel
5.1.3 Public Distribution Channel
5.2 By Application – Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
5.2.1 By Application – Global Measles and Rubella (MR) Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Measles and Rubella (MR) Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Measles and Rubella (MR) Vaccine Sales & Forecasts
5.3.1 By Application – Global Measles and Rubella (MR) Vaccine Sales, 2018-2023
5.3.2 By Application – Global Measles and Rubella (MR) Vaccine Sales, 2024-2029
5.3.3 By Application – Global Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Measles and Rubella (MR) Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Measles and Rubella (MR) Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
6.2.1 By Region – Global Measles and Rubella (MR) Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Measles and Rubella (MR) Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Measles and Rubella (MR) Vaccine Sales & Forecasts
6.3.1 By Region – Global Measles and Rubella (MR) Vaccine Sales, 2018-2023
6.3.2 By Region – Global Measles and Rubella (MR) Vaccine Sales, 2024-2029
6.3.3 By Region – Global Measles and Rubella (MR) Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Measles and Rubella (MR) Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Measles and Rubella (MR) Vaccine Sales, 2018-2029
6.4.3 US Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.4.4 Canada Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.4.5 Mexico Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Measles and Rubella (MR) Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Measles and Rubella (MR) Vaccine Sales, 2018-2029
6.5.3 Germany Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.4 France Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.5 U.K. Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.6 Italy Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.7 Russia Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.5.9 Benelux Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Measles and Rubella (MR) Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Measles and Rubella (MR) Vaccine Sales, 2018-2029
6.6.3 China Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.6.4 Japan Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.6.5 South Korea Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.6.7 India Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Measles and Rubella (MR) Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Measles and Rubella (MR) Vaccine Sales, 2018-2029
6.7.3 Brazil Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.7.4 Argentina Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Measles and Rubella (MR) Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Measles and Rubella (MR) Vaccine Sales, 2018-2029
6.8.3 Turkey Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.8.4 Israel Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Measles and Rubella (MR) Vaccine Market Size, 2018-2029
6.8.6 UAE Measles and Rubella (MR) Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 PT Bio Farma
7.1.1 PT Bio Farma Company Summary
7.1.2 PT Bio Farma Business Overview
7.1.3 PT Bio Farma Measles and Rubella (MR) Vaccine Major Product Offerings
7.1.4 PT Bio Farma Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 PT Bio Farma Key News & Latest Developments
7.2 Bio-Manguinhos
7.2.1 Bio-Manguinhos Company Summary
7.2.2 Bio-Manguinhos Business Overview
7.2.3 Bio-Manguinhos Measles and Rubella (MR) Vaccine Major Product Offerings
7.2.4 Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Bio-Manguinhos Key News & Latest Developments
7.3 BE Vaccines
7.3.1 BE Vaccines Company Summary
7.3.2 BE Vaccines Business Overview
7.3.3 BE Vaccines Measles and Rubella (MR) Vaccine Major Product Offerings
7.3.4 BE Vaccines Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 BE Vaccines Key News & Latest Developments
7.4 Crucell Switzerland AG
7.4.1 Crucell Switzerland AG Company Summary
7.4.2 Crucell Switzerland AG Business Overview
7.4.3 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Major Product Offerings
7.4.4 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Crucell Switzerland AG Key News & Latest Developments
8 Global Measles and Rubella (MR) Vaccine Production Capacity, Analysis
8.1 Global Measles and Rubella (MR) Vaccine Production Capacity, 2018-2029
8.2 Measles and Rubella (MR) Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Measles and Rubella (MR) Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Measles and Rubella (MR) Vaccine Supply Chain Analysis
10.1 Measles and Rubella (MR) Vaccine Industry Value Chain
10.2 Measles and Rubella (MR) Vaccine Upstream Market
10.3 Measles and Rubella (MR) Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Measles and Rubella (MR) Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 麻疹・おたふく風邪・風疹ウイルスワクチンのグローバル市場展望 2023年-2029年：子供、大人
  • 麻疹ワクチンのグローバル市場展望 2023年-2029年：おたふく風邪・麻疹・風疹生ワクチン（MMR-II）、おたふく風邪・麻疹・風疹・水痘ウイルスワクチン（Proquad）
  • 無針インフルエンザワクチンのグローバル市場展望 2023年-2029年：弱毒化生インフルエンザワクチン、スプリットインフルエンザワクチン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5739 )"麻疹・風疹（MR）ワクチンのグローバル市場展望 2023年-2029年：MRワクチン、MRBEVワクチン" (英文：Measles and Rubella (MR) Vaccine Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。